|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yang K, Chen XZ and Hu JK: Factors
associated with recurrence and survival in N0 gastric cancer. Ann
Surg. 266:e10–e11. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhang F, Yan Y, Cao X, Zhang J, Li Y and
Guo C: Methylation of microRNA-338-5p by EED promotes
METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Aging (Albany NY). 13:12224–12238. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Billones R, Liwang JK, Butler K, Graves L
and Saligan LN: Dissecting the fatigue experience: A scoping review
of fatigue definitions, dimensions, and measures in non-oncologic
medical conditions. Brain Behav Immun Health.
15(100266)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tian J and Hong JS: Validation of the
Chinese version of multidimensional fatigue Inventory-20 in Chinese
patients with cancer. Support Care Cancer. 20:2379–2383.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li X, Xia L, Ouyang X, Suyila Q, Su L and
Su X: Bioactive peptides sensitize cells to anticancer effects of
oxaliplatin in human colorectal cancer xenografts in nude mice.
Protein Pept Lett. 26:512–522. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Su X, Dong C, Zhang J, Su L, Wang X, Cui H
and Chen Z: Combination therapy of anti-cancer bioactive peptide
with Cisplatin decreases chemotherapy dosing and toxicity to
improve the quality of life in xenograft nude mice bearing human
gastric cancer. Cell Biosci. 4(7)2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li X, Gao B and Su X: Anticancer bioactive
peptide combined with docetaxel and its mechanism in the treatment
of breast cancer. Exp Ther Med. 20:1917–1924. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li X, Wu H, Ouyang X, Zhang B and Su X:
New bioactive peptide reduces the toxicity of chemotherapy drugs
and increases drug sensitivity. Oncol Rep. 38:129–140.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang X, Guo J, Wang Y, Xiao Y, Wang L and
Hua S: Expression levels of interferon regulatory factor 5 (IRF5)
and related inflammatory cytokines associated with severity,
prognosis, and causative pathogen in patients with
community-acquired pneumonia. Med Sci Monit. 24:3620–3630.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Garlanda C, Dinarello CA and Mantovani A:
The interleukin-1 family: Back to the future. Immunity.
39:1003–1018. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gao LB, Pan XM, Jia J, Liang WB, Rao L,
Xue H, Zhu Y, Li SL, Lv ML, Deng W, et al: IL-8-251A/T polymorphism
is associated with decreased cancer risk among population-based
studies: Evidence from a meta-analysis. Eur J Cancer. 46:1333–1343.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Patidar M, Yadav N and Dalai SK:
Interleukin 15: A key cytokine for immunotherapy. Cytokine Growth
Factor Rev. 31:49–59. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Abusleme L and Moutsopoulos NM: IL-17:
Overview and role in oral immunity and microbiome. Oral Dis.
23:854–865. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen S, Shen Z, Liu Z, Gao L, Han Z, Yu S
and Kang M: IL-1RA suppresses esophageal cancer cell growth by
blocking IL-1α. J Clin Lab Anal. 33(e22903)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zheng N and Lu Y: Targeting the IL-9
pathway in cancer immunotherapy. Hum Vaccin Immunother.
16:2333–2340. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kalayci M and Gul E: Eotaxin-1 levels in
patients with myocardial infarction. Clin Lab: 68, 2022 doi:
10.7754/Clin.Lab.2021.210806.
|
|
18
|
Pereiro P, Figueras A and Novoa B:
Insights into teleost interferon-gamma biology: An update. Fish
Shellfish Immunol. 90:150–164. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Melincovici CS, Boşca AB, Şuşman S,
Mărginean M, Mihu C, Istrate M, Moldovan IM, Roman AL and Mihu CM:
Vascular endothelial growth factor (VEGF)-key factor in normal and
pathological angiogenesis. Rom J Morphol Embryol. 59:455–467.
2018.PubMed/NCBI
|
|
20
|
Gao SY, Lin RB, Huang SH, Liang YJ, Li X,
Zhang SE, Ouyang DQ, Li K, Zheng GS and Liao GQ: PDGF-BB exhibited
therapeutic effects on rat model of bisphosphonate-related
osteonecrosis of the jaw by enhancing angiogenesis and
osteogenesis. Bone. 44(115117)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Khajvand T, Huang P, Li L, Zhang M, Zhu F,
Xu X, Huang M, Yang C, Lu Y and Zhu Z: Interfacing droplet
microfluidics with antibody barcodes for multiplexed single-cell
protein secretion profiling. Lab Chip. 21:4823–4830.
2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Qian Y, He Z, Zhao SS, Liu B, Chen Y, Sun
X, Ye D, Jiang X, Zheng H, Wen C, et al: Genetically determined
circulating levels of cytokines and the risk of rheumatoid
arthritis. Front Genet. 13(802464)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Castellani ML, De Lutiis MA, Toniato E,
Conti F, Felaco P, Fulcheri M, Theoharides TC, Caraffa A, Antinolfi
P, Conti P, et al: Impact of RANTES, MCP-1 and IL-8 in mast cells.
J Biol Regul Homeost Agents. 24:1–6. 2010.PubMed/NCBI
|
|
24
|
Ntanasis-Stathopoulos I, Fotiou D and
Terpos E: CCL3 signaling in the tumor microenvironment. Adv Exp Med
Biol. 1231:13–21. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Jiang Y, Huang F, Chai X, Yuan W, Ding H
and Wu X: The role of IP-10 and its receptor CXCR3 in early
pregnancy. Mol Immunol. 140:59–69. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Becher B, Tugues S and Greter M: GM-CSF:
From growth factor to central mediator of tissue inflammation.
Immunity. 45:963–973. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kanda T, Yoshida A, Ogihara K, Minami H,
Yamaguchi N, Ikebuchi Y, Nakao K and Isomoto H: Detection of
cytokine storm in patients with achalasia using ELISA. Biomed Rep.
15(62)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bernstein JM, Ballow M, Xiang S and O'Neil
K: Th1/Th2 cytokine profiles in the nasopharyngeal lymphoid tissues
of children with recurrent otitis media. Ann Otol Rhinol Laryngol.
107:22–27. 1998.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Abbas AK, Trotta E, R Simeonov D, Marson A
and Bluestone JA: Revisiting IL-2: Biology and therapeutic
prospects. Sci Immunol. 3(eaat1482)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Iwaszko M, Biały S and Bogunia-Kubik K:
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory
Arthritis. Cells. 10(3000)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tanaka T, Narazaki M and Kishimoto T:
Interleukin (IL-6) immunotherapy. Cold Spring Harb Perspect Biol.
10(a028456)2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yan B, Wei JJ, Yuan Y, Sun R, Li D, Luo J,
Liao SJ, Zhou YH, Shu Y, Wang Q, et al: IL-6 cooperates with G-CSF
to induce protumor function of neutrophils in bone marrow by
enhancing STAT3 activation. J Immunol. 190:5882–5893.
2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yaseen MM, Abuharfeil NM, Darmani H and
Daoud A: Mechanisms of immune suppression by myeloid-derived
suppressor cells: The role of interleukin-10 as a key
immunoregulatory cytokine. Open Biol. 10(200111)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Saraiva M, Vieira P and O'Garra A: Biology
and therapeutic potential of interleukin-10. J Exp Med.
217(e20190418)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wang C, Kong L, Kim S, Lee S, Oh S, Jo S,
Jang I and Kim TD: The Role of IL-7 and IL-7R in cancer
pathophysiology and immunotherapy. Int J Mol Sci.
23(10412)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nguyen KG, Vrabel MR, Mantooth SM, Hopkins
JJ, Wagner ES, Gabaldon TA and Zaharoff DA: Localized
Interleukin-12 for cancer immunotherapy. Front Immunol.
11(575597)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Achuthan AA, Lee KMC and Hamilton JA:
Targeting GM-CSF in inflammatory and autoimmune disorders. Semin
Immunol. 54(101523)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kursunel MA and Esendagli G: The untold
story of IFN-γ in cancer biology. Cytokine Growth Factor Rev.
31:73–81. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y
and Li Y: Inflammation and tumor progression: Signaling pathways
and targeted intervention. Signal Transduct Target Ther.
6(263)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Micev M and Cosić-Micev M: Pathology and
pathobiology of the gastric carcinoma. Acta Chir Iugosl. 58:39–52.
2011.PubMed/NCBI View Article : Google Scholar : (In Serbian).
|
|
41
|
Tu S, Bhagat G, Cui G, Takaishi S,
Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl
O, Fox JG and Wang TC: Overexpression of interleukin-1beta induces
gastric inflammation and cancer and mobilizes myeloid-derived
suppressor cells in mice. Cancer Cell. 14:408–419. 2008.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Cheng D, Hao Y, Zhou W and Ma Y: Positive
association between Interleukin-8-251A>T polymorphism and
susceptibility to gastric carcinogenesis: A meta-analysis. Cancer
Cell Int. 13(100)2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sun PS, Gao ZJ, Fan LX, Liu YF, Chen BH,
Mu SZ and Yan ZQ: The regulatory function of tumor-infiltrating Th9
cells to anti-tumor activity of CD8(+) T cells in patients with
gastric cancer. Zhonghua Zhong Liu Za Zhi. 44:1186–1193.
2022.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
44
|
Jakobisiak M, Golab J and Lasek W:
Interleukin 15 as a promising candidate for tumor immunotherapy.
Cytokine Growth Factor Rev. 22:99–108. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Shi JL, Zheng ZM, Chen M, Shen HH, Li MQ
and Shao J: IL-17: An important pathogenic factor in endometriosis.
Int J Med Sci. 19:769–778. 2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Meng XY, Zhou CH, Ma J, Jiang C and Ji P:
Expression of interleukin-17 and its clinical significance in
gastric cancer patients. Med Oncol. 29:3024–3028. 2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Florkiewicz RZ, Ahluwalia A, Sandor Z,
Szabo S and Tarnawski AS: Gastric mucosal injury activates bFGF
gene expression and triggers preferential translation of high
molecular weight bFGF isoforms through CUG-initiated, non-canonical
codons. Biochem Biophys Res Commun. 409:494–499. 2011.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Xue Y, Lim S, Yang Y, Wang Z, Jensen LD,
Hedlund EM, Andersson P, Sasahara M, Larsson O, Galter D, et al:
PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing
erythropoietin production in stromal cells. Nat Med. 18:100–110.
2011.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Shi L, Wang L and Wang X: Osteopontin
induces Epithelial-to-Mesenchymal transitions in human lung cancer
cells via PI3K/Akt and MEK/Erk1/2 signaling pathways. Chest.
149(A332)2016.
|
|
50
|
Ruhwald M, Aabye MG and Ravn P: IP-10
release assays in the diagnosis of tuberculosis infection: Current
status and future directions. Expert Rev Mol Diagn. 12:175–187.
2012.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Singh S, Anshita D and Ravichandiran V:
MCP-1: Function, regulation, and involvement in disease. Int
Immunopharmacol. 101(107598)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yoshimura T: The chemokine MCP-1 (CCL2) in
the host interaction with cancer: A foe or ally? Cell Mol Immunol.
15:335–345. 2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Hata H: Bone lesions and macrophage
inflammatory protein-1 alpha (MIP-1a) in human multiple myeloma.
Leuk Lymphoma. 46:967–972. 2005.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Schröder JM: Peptides and cytokines. Arch
Dermatol Res. 284 (Suppl 1):S22–S26. 1992.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Shim YJ, Kang BH, Choi BK, Park IS and Min
BH: Clusterin induces the secretion of TNF-α and the chemotactic
migration of macrophages. Biochem Biophys Res Commun. 422:200–205.
2012.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Propst SM, Estell K and Schwiebert LM:
CD40-mediated activation of NF-kappa B in airway epithelial cells.
J Biol Chem. 277:37054–37063. 2002.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Wang Y, Bao M, Hou C, Wang Y, Zheng L and
Peng Y: The Role of TNF-α in the pathogenesis of Temporomandibular
disorders. Biol Pharm Bull. 44:1801–1809. 2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Peng K, Bai Y, Zhu Q, Hu B and Xu Y:
Targeting VEGF-neuropilin interactions: A promising antitumor
strategy. Drug Discov Today. 24:656–664. 2019.PubMed/NCBI View Article : Google Scholar
|
